LUNDBECK INSTITUTE
LIVE

Serial Number

98553575

Owner

H. Lundbeck A/S

Attorney

Maren C. Perry

Filing Date

May 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LUNDBECK INSTITUTE Trademark

Serial Number: 98553575 • Registration: 7814488

LUNDBECK INSTITUTE is a trademark filed by H. Lundbeck A/S on May 16, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

May 16, 2024

Registration Date

June 3, 2025

Published for Opposition

April 15, 2025

Goods & Services

Educational services, namely, conducting seminars in the field of pharmaceuticals and disease awareness; providing of training in the nature of conferences, courses, seminars and workshops in the field of pharmaceuticals and disease awareness; arranging and conducting seminars, conferences, symposiums, training workshops and courses in the field of pharmaceuticals and disease awareness; educational training services in the nature of conferences, courses, seminars and workshops in the fields of pharmaceutical research and development, medical clinical studies, pharmaceutical tests and trials and diagnostic medicine related to the treatment and prevention of diseases and disorders; providing the aforementioned services electronically in the nature of online and non-downloadable, on-line, via cable and Internet and other electronic media, namely, podcasts, audio and visual media; arranging and conducting expert forums, namely, on-line training programs in the field of pharmaceuticals; providing online, non- downloadable publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, science, medical clinical studies in the field of pharmaceutical tests and trials, diagnostic medicine, pharmaceuticals, disorders, disease awareness, treatment and prevention related to the assessment of cognitive functions; providing educational assessment services in the field of cognitive functions through on-line non- downloadable screening tools

Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, disease awareness, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine, medicine, pharmaceuticals, disorders, diseases, clinical or medical treatment and prevention; downloadable and recorded computer software for creating searchable databases of medical and pharmaceutical information, education, namely, educational software featuring instruction in medicine and sales activities, namely, software for others for use in sales management; downloadable and recorded computer software for analyzing medical and pharmaceutical information and disease awareness; software, namely, downloadable and recorded application software for mobile devices in the nature of mobile phones, namely, software for analyzing medical and pharmaceutical information; apparatus and instruments, namely, downloadable computer software for analyzing medical and pharmaceutical information in the field of research and development, science, clinical studies, medical clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; electronic downloadable publications, namely, magazines, journals, teaching and educational materials in the field of pharmaceutical research and development, science, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine related to clinical or medical treatment and prevention; downloadable and recorded application software for mobile devices in the nature of mobile phones, namely, software for the assessment of cognitive functions; downloadable computer software for the assessment of cognitive functions; downloadable and recorded computer software for use in diagnosing, managing, monitoring, assessing, controlling and examining psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, migraine, pain, alcoholism and dependency on drugs, alcohol, nicotine and caffeine

Arranging and conducting an online forum in the field of pharmaceuticals, disease awareness and treatments; providing online chat rooms and electronic bulletin boards for transmission of messages among computer users in the field of pharmaceuticals, disease awareness and treatments

Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances, for the treatment of disorders and diseases acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood swings, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinsons disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and suffering, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourettes syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, drowsiness, nausea, migraine, pain, alcoholism and addiction; diagnostic preparations, substances, reagents and agents for medical purposes

Printed publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, records in the nature of informational sheets, educational and training materials for research and development, science, clinical studies, tests and trials, diagnostics, medicine, drugs, disorders, diseases, treatment and prevention

Pharmaceutical research and development; scientific and technological services, namely, scientific testing and research related to medical disorders, medical diseases and medical prevention; scientific and technological services, namely, scientific testing and research related to the central nervous system and central nervous system related disorders, pharmaceuticals and disease awareness; medical and clinical research, namely, pharmaceutical clinical research and conducting clinical trials for others in the field of pharmaceuticals; diagnostic research and tests, namely, providing diagnostic services for others for scientific research purposes in the field of pharmaceutical research

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 3, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 3, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 19, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 4, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 2, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2024 NWOS
NEW APPLICATION ENTERED
May 16, 2024 NWAP